Trial intelligence / Profile preview

Fluoxetine for moderate to severe irritable bowel syndrome in adults

IRCT138805012159N2Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluoxetine in irritable bowel syndrome (IBS), sponsored by Isfahan University of Medical Sciences. Started Jun 2010; status: completed.

02

Drugs

fluoxetine
03

Conditions

irritable bowel syndrome (IBS)

Beyond the preview

Go deeper on IRCT138805012159N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138805012159N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call